Mon.Jun 23, 2025

article thumbnail

CII hosts ‘Pillars of Protection’ conference in Hyderabad to address safety in pharma manufacturing

Express Pharma

The Confederation of Indian Industry (CII), Telangana, hosted the ‘Pillars of Protection: Forging a Safer Future for Pharma and Chemical Manufacturing’ conference on 25 June 2025 in Hyderabad. The event convened regulators, safety professionals, technologists, policy experts, and industry leaders to discuss actionable strategies for enhancing safety and sustainability across pharma and chemical manufacturing operations in India.

article thumbnail

Megablockbusters are the holy grail. Here’s how drugmakers are getting there.

PharmaVoice

Skip to main content CONTINUE TO SITE ➞ Dont miss the most important voices in pharma Let PharmaVoices free newsletter keep you informed on what industry leaders are saying, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Deve

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

CII to host ‘Pillars of Protection’ conference in Hyderabad to address safety in pharma manufacturing

Express Pharma

The Confederation of Indian Industry (CII), Telangana, is set to organise a one-day conference titled ‘Pillars of Protection: Forging a Safer Future for Pharma and Chemical Manufacturing’ on 25 June 2025 in Hyderabad. The event will bring together regulators, safety professionals, technologists, policy experts, and industry leaders to explore strategies for strengthening safety and sustainability within pharmaceutical and chemical manufacturing in India.

article thumbnail

What is Cost-Per-Action in Pharma Marketing?

Pharma Marketing Network

Imagine paying for results instead of exposure. That’s the value proposition behind Cost-Per-Action (CPA) advertising in pharma marketing. In a landscape driven by compliance, outcomes, and ROI, CPA offers a performance-based model that aligns with healthcare marketers’ evolving needs. But how exactly does it work, and why is it gaining traction in the pharmaceutical industry?

article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Transitions of Care Pharmacists Mitigate Readmission Rates for COPD

Pharmacy Times

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

article thumbnail

How to Track Competitor R&D Pipelines Through Drug Patent Filings

Drug Patent Watch

Patent filings represent one of the most valuable yet underutilized sources of competitive intelligence in the pharmaceutical industry.

More Trending

article thumbnail

Cassidy calls to delay meeting of CDC’s vaccine panel in challenge to RFK Jr.

STAT

WASHINGTON — A key Senate health leader is calling for this week’s meeting of the panel of vaccine advisers handpicked by Health and Human Services Secretary Robert F. Kennedy Jr. to be delayed, citing their lack of experience and potential bias against some vaccines. “Although the appointees to [the Advisory Committee on Immunization Practices] have scientific credentials, many do not have significant experience studying microbiology, epidemiology or immunology.

article thumbnail

Ecommerce Prescribing Clinic – The Ultimate Tech Stack

pharmacy mentor

More and more, pharmacies are moving to offer their services online. These can be traditional pharmacies that want to capture more patients or new online only pharmacies that are just starting up. These e-commerce prescribing clinics are a great way to increase revenue and empower your customers but they are not as simple as they may first appear. Running a successful e-commerce prescribing clinic can be complicated.

article thumbnail

Lorundrostat Shows Clinically Meaningful Outcomes in Patients With CKD and Hypertension

Pharmacy Times

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

article thumbnail

Why most extractables & leachables studies fail regulatory review-and how to fix them

Express Pharma

Introduction Extractables and Leachables (E&L) testing has become non-negotiable for pharmaceuticals, biologics, and combination products. Regulatory agencies such as the US FDA, EMA, CDSCO, and WHO increasingly demand robust, risk-based E&L data-not just lab reports. However, in our experience at SG Pharma Solutions, more than 60 per cent of initial E&L submissions get flagged.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Evaluate Issues Annual World Preview Report

Pharmaceutical Commerce

News News Pharma Pulse Academy Publications Partner Perspectives Webcasts Resources Conferences Conference Coverage Conference Listing Events Videos Videos Peer Exchange Podcasts Editorial Podcasts Sponsored Podcasts Subscribe Choose Specialty Brand & Product Security Brand & Product Security Brand & Product Security Brand & Product Security Business and Finance Cold Chain Cold Chain Cold Chain Cold Chain Commercial Channels Data & Technology Data & Technology Data &

article thumbnail

ADA 2025: Advances in Type 2 Diabetes Management With Tirzepatide

Pharmacy Times

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

article thumbnail

STAT+: Novo Nordisk ends deal with Hims due to compounding concerns with obesity drugs

STAT

Novo Nordisk is ending a deal with telehealth company Hims & Hers, saying Monday that Hims has been engaging in “illegal mass compounding” of GLP-1 obesity treatments and “deceptive marketing.” Earlier this year, Novo launched a direct-to-consumer website that sells its obesity drug Wegovy at a lower price to patients who are paying on their own without insurance.

article thumbnail

ADA 2025: Ready-to-Use Glucagon Empowers Diabetes Patient Safety

Pharmacy Times

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

CORONA Remedies appoints four independent directors to strengthen board governance

Express Pharma

CORONA Remedies, an India-focused pharma company backed by Sepia Investments, an affiliate of ChrysCapital, has appointed four Independent Directors to its Board of Directors. The new appointees—Ameetkumar Hiranyakumar Desai, Bhaskar Vemban Iyer, Shirish Gundopant Belapure, and Monica Hemal Kanuga—bring with them a range of experience across strategic, operational, and governance functions.

article thumbnail

Hidden in Plain Sight: Recognizing Signs and Symptoms of Tardive Dyskinesia

Pharmacy Times

Panelists discuss how enhancing the management of tardive dyskinesia in elderly patients involves recognizing subtle clinical signs, addressing mental health stigma, and leveraging the pivotal role of pharmacists in early detection, patient education, and coordinated, compassionate care.

article thumbnail

EC approves argenx’s efgartigimod alfa for CIDP treatment

Pharmaceutical Technology

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

article thumbnail

Targeting fusion protein's role in childhood leukemia produces striking results

World Pharma News

Scientists at St. Jude Children's Research Hospital and Dana-Farber Cancer Institute today report the identification of a novel combination therapy approach to treat pediatric acute myeloid leukemia (AML). Standard treatment is often ineffective against AML, a cancer that commonly relapses with poor prognosis, particularly when the disease is fueled by fusion proteins involving NUP98.

article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Neurizon confirms positive results for prospective ALS treatment

Pharmafile

Neurizon Therapeutics has announced new preclinical data confirming that NUZ-001 and its active metabolite, NUZ-001 Sulfone, effectively cross the blood-brain barrier (BBB) and reach concentrations in the brain sufficient to reverse toxic TDP-43 protein aggregation – a key driver of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS).

article thumbnail

Why Pharma Marketers Are Interested in Real-Time Bidding

Pharma Marketing Network

Imagine if pharmaceutical ads could reach specific healthcare professionals or patients the moment they searched for relevant content. That’s the promise of Real-Time Bidding (RTB), a programmatic advertising technology that is revolutionizing how pharma marketers reach their audiences. In an industry where precision, compliance, and personalization are essential, RTB offers a scalable, data-driven solution that aligns perfectly with modern marketing strategies.

article thumbnail

Regulatory shift signals potential change for future CGT sector

European Pharmaceutical Review

With the biopharma industry experiencing notable shifts in recent months and subsequent policy and market uncertainty, the pharmaceutical cell and gene therapy sector has undergone another central change. Commenting on 19 June, the Alliance for Regenerative Medicine (ARM) stated it is “deeply disappointed” with news that two US FDA Directors have been placed on administrative leave.

article thumbnail

Harbour BioMed partners Otsuka on new T-cell therapy

Pharmaceutical Technology

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

IVIG-Glucocorticoid Combination Therapy Reduces Need for Adjunctive Immunotherapy in Pediatric MIS-C

Pharmacy Times

Glucocorticoids alone were found to reduce treatment failure and fever duration, but the combination with intravenous immunoglobulin (IVIG) significantly reduced the need for adjunctive immunotherapy following treatment.

article thumbnail

STAT+: Top drug regulator is retiring as FDA departures mount

STAT

WASHINGTON — Jacqueline Corrigan-Curay, the top drug regulator at the Food and Drug Administration, is retiring from the agency in July.  Corrigan-Curay, who took over as acting director of the Center for Drug Evaluation and Research in January, broke the news to staff in an email shared with STAT. She said she decided to leave the agency after taking a recent vacation, and thanked staff for their “unwavering support, especially during recent challenging times.

article thumbnail

Understanding the Impact of Tardive Dyskinesia Across Patient Populations

Pharmacy Times

Panelists discuss how the progression of undiagnosed or untreated tardive dyskinesia in older adults can severely compromise independence and quality of life, emphasizing the need for early recognition, risk factor management, and a multidisciplinary approach—including pharmacists—to ensure timely, individualized, and balanced treatment.

article thumbnail

EU kicks off review of GSK's linerixibat in PBC

pharmaphorum

GSK's drug for severe itching in patients with autoimmune liver disease PBC is now under review in the EU and US, as Mirum Pharma tries to catch up.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

FDA Approves Celltrion’s New Pediatric Formulation of STEQEYMA, Expanding Dosing Flexibility

Big Molecule Watch

On June 15, 2025, Celltrion announced that the FDA has approved a new 45mg/0.5mL single-dose vial presentation of STEQEYMA (ustekinumab-stba) for subcutaneous injection. The formulation is intended for pediatric patients (ages 6–17) under 60kg with plaque psoriasis (PsO) or psoriatic arthritis (PsA). With this approval, STEQEYMA now matches all dosage forms and strengths of its reference product, STELARA, including 45mg/0.5mL and 90mg/mL prefilled syringes (subcutaneous), and 130mg/26mL vials

article thumbnail

Compass’ big psychedelic study doesn’t impress investors

BioPharma Dive

While positive, results from a late-stage clinical trial appear to be raising questions about how useful the company’s version of psilocybin could be as a depression treatment.

article thumbnail

Current Perspective on Pricing and Reimbursement Models

Pharmaceutical Commerce

Leading stakeholders in the industry react to how evolving US policies, payer demands, and vertical integration are reshaping market access strategy, stressing the importance of early planning and the urgency of ensuring that innovative therapies are available and affordable for patients.

article thumbnail

Teva and Fosun Partner to Develop a Novel Immunotherapy Targeting Melanoma and Other Cancers

Big Molecule Watch

Teva Pharmaceutical Industries Ltd. (“Teva”) and Shanghai Fosun Pharmaceutical (Group) Co. (“Fosun Pharma”) recently announced a partnership to accelerate the development of Teva’s TEV-56278, a novel fusion protein that uses Teva’s ATTENUKINE technology to target cytokine activity to tumor cells while reducing toxic side effects.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.